New Plastic Makes Administering Drugs Safer
Inferior materials often cannot withstand cleaning agents, nor can they tolerate aggressive solvents typically found in oncology drugs and other treatments. This may result in cracking and damage to important components. Makrolon Rx3440, a new medical polycarbonate from Covestro LLC, offers superior durability and chemical resistance to help prevent cracking so that health care professionals can deliver oncology drugs to patients more safely. Comprehensive laboratory testing has confirmed that this polycarbonate provides better chemical and oncology drug resistance than other transparent resins used for IV access components. This material also demonstrates the best retention of stress to provide more reliable IV connections.
Medical technology manufacturers can also benefit from further advantages when using Makrolon Rx3440:
- Biocompatible according to ISO 10993-1 and USP Class IV standards
- Greater structural integrity to allow for thin-walled parts
- Toughness to resist mishandling
- Good dimensional stability in shipping and storage
Covestro has designed its own testing apparatus to enable customers to test the chemical resistance of their Luer components.